Compare CRCT & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | WVE |
|---|---|---|
| Founded | 1969 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2021 | 2015 |
| Metric | CRCT | WVE |
|---|---|---|
| Price | $4.95 | $18.27 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $4.18 | ★ $29.94 |
| AVG Volume (30 Days) | 452.9K | ★ 13.7M |
| Earning Date | 11-04-2025 | 11-10-2025 |
| Dividend Yield | ★ 19.39% | N/A |
| EPS Growth | ★ 27.98 | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $714,492,000.00 | $109,230,000.00 |
| Revenue This Year | $1.06 | N/A |
| Revenue Next Year | N/A | $16.00 |
| P/E Ratio | $13.26 | ★ N/A |
| Revenue Growth | N/A | ★ 103.75 |
| 52 Week Low | $3.94 | $5.28 |
| 52 Week High | $7.33 | $21.73 |
| Indicator | CRCT | WVE |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 68.21 |
| Support Level | $4.94 | $15.23 |
| Resistance Level | $5.35 | $17.41 |
| Average True Range (ATR) | 0.14 | 2.06 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 8.79 | 75.73 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.